Avadel Pharmaceuticals PLC (AVDL)

Q: Does AVDL pay dividends?

Avadel Pharmaceuticals PLC (AVDL) does not currently pay a regular dividend.

Official site

DRUG MANUFACTURERS - SPECIALTY & GENERIC

$21.64

+0.00 (+0.00%)

Last updated: Feb 12, 2026 at 4:00 PM ET

Earnings

Performance (10Y)

Beat Rate

62%(23/37)

Avg Surprise

+339.54%

Last 12 of 37 reported quarters

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2025Dec 25 Reported Mar 9, 2026Reported Mar 9	$0.00	N/A	-	-100.00%	Miss	6	-	+100.0%
Sep 30, 2025Sep 25 Reported Nov 4, 2025Reported Nov 4	$0.00	N/A	-	-99.71%	Miss	7	0 1 30d	+100.7%
Jun 30, 2025Jun 25 Reported Aug 7, 2025Reported Aug 7	$0.10	$0.02	$0.02 - $0.05	+400.00%	Beat	4	3 0 30d	+171.4%
Mar 31, 2025Mar 25 Reported May 7, 2025Reported May 7	$-0.05	$-0.07	$-0.14 - $-0.03	+28.57%	Beat	4	No revisions (30d)	+83.3%
Dec 31, 2024Dec 24 Reported Mar 3, 2025Reported Mar 3	$-0.05	$-0.05	$-0.11 - $-0.03	+0.00%	Beat	5	-	+84.4%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-0.03	$-0.06	$-0.11 - $-0.01	+50.00%	Beat	10	No revisions (30d)	+92.7%
Jun 30, 2024Jun 24 Reported Aug 8, 2024Reported Aug 8	$-0.14	$-0.17	$-0.21 - $-0.01	+17.65%	Beat	10	1 0 30d	+80.0%
Mar 31, 2024Mar 24 Reported May 8, 2024Reported May 8	$-0.30	$-0.25	$-0.31 - $-0.01	-20.00%	Miss	9	1 0 30d	+37.5%
Dec 31, 2023Dec 23 Reported Mar 4, 2024Reported Mar 4	$-0.32	$-0.28	-	-14.29%	Miss	9	No revisions (30d)	+27.3%
Sep 30, 2023Sep 23 Reported Nov 8, 2023Reported Nov 8	$-0.41	$-0.35	$-0.42 - $-0.32	-17.14%	Miss	8	1 0 30d	-24.2%
Jun 30, 2023Jun 23 Reported Aug 9, 2023Reported Aug 9	$-0.70	$-0.39	$-0.41 - $-0.33	-79.49%	Miss	7	1 0 30d	-40.0%
Mar 31, 2023Mar 23 Reported May 4, 2023Reported May 4	$-0.48	$-0.37	$-0.48 - $-0.22	-29.73%	Miss	8	1 3 30d	-6.7%

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	N/A	Quick Ratio	N/A
Trading Statistics
Beta	N/A	Avg Volume	N/A
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$21.61

SMA 20$21.57

SMA 50$21.50

SMA 200N/A

EMA 10$21.61

EMA 20$21.58

EMA 50$21.16

EMA 200$16.79

MACD

Line: 0.06Signal: 0.06Hist: -0.00

ADX

ADX: 46.5+DI: 27.3-DI: 6.1

Aroon & PSAR

Aroon Up96.0

Aroon Down4.0

PSAR$22.02

Bollinger Bands

Upper Band$21.68

Lower Band$21.45

%B Position107%(Upper)

Band Width0.82

RSI (14-Day)

Neutral

61.6

Momentum Oscillators

Stoch %K55.9

Stoch %D62.7

Williams %R-48.0

ROC (10d)0.4%

Momentum0.08

CCI (20d)93.3

MFI (14d)90.8

Volatility Measures

ATR (14d)$0.08(0.4%)

StdDev (20d)0.06

Hist Vol2.5%(Low)

Volume Flow

VWAP$21.64

OBV109.2M

AD Line-27.1M

CMF (20d)-0.728

Volume Metrics

Avg Vol (20d)3.0M

Vol Ratio0.0x(Low)

VWMA (20d)$21.61

Pivot Points

R3$21.85

R2$21.81

R1$21.72

Pivot Point$21.68

S1$21.59

S2$21.55

S3$21.46

Advanced Oscillators

TSI21.22

Ultimate Osc28.5

KST5.15

Financial Data

Quarter	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022
Total Revenue	$77.47M	$68.13M	$52.51M	$50.41M	$50.02M	$41.50M	$27.18M	$19.45M	$7.01M	$1.50M	$0	$0
Cost of Revenue	$-3,001,000	$6.37M	$5.58M	$4.81M	$6.16M	$2.79M	$1.52M	$693,000	$117,000	$36,000	$0	$586,000
Gross Profit	$80.47M	$61.76M	$46.93M	$45.60M	$43.87M	$38.72M	$25.66M	$18.76M	$6.90M	$1.46M	$0	$-586,000

Operating Expenses	$78.53M	$52.88M	$49.94M	$48.90M	$44.20M	$51.46M	$51.69M	$43.66M	$42.01M	$51.00M	$28.30M	$22.63M
R&D	$27.01M	$4.25M	$4.35M	$4.27M	$3.80M	$4.05M	$3.07M	$2.36M	$2.85M	$4.22M	$3.83M	$6.24M
SG&A	$51.52M	$48.62M	$45.58M	$44.62M	$40.39M	$47.41M	$48.62M	$41.30M	$39.16M	$46.78M	$24.47M	$16.39M
Operating Income	$1.94M	$8.88M	$-3,001,000	$-3,297,000	$-327,000	$-12,741,000	$-26,035,000	$-24,900,000	$-35,110,000	$-49,541,000	$-28,298,000	$-23,216,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$2.42M	$2.35M	$2.24M	$2.70M	$2.82M	$2.72M	$2.59M	$2.35M	$1.98M	$2.29M	$3.26M	$3.25M
Income Before Tax	$54,000	$6.50M	$-4,842,000	$-4,963,000	$-2,537,000	$-14,331,000	$-27,249,000	$-28,886,000	$-36,185,000	$-64,342,000	$-31,364,000	$-27,365,000
Income Tax Expense	$34,000	$-3,170,000	$78,000	$80,000	$88,000	$-509,000	$93,000	$-100,000	$89,000	$90,000	$-580,000	$85,000

Net Income	$20,000	$9.66M	$-4,920,000	$-5,043,000	$-2,625,000	$-13,822,000	$-27,342,000	$-28,786,000	$-36,274,000	$-64,432,000	$-30,784,000	$-27,450,000

EBITDA	$3.58M	$9.92M	$-1,779,000	$-1,593,000	$1.32M	$-11,178,000	$-24,116,000	$-26,532,000	$-33,612,000	$-61,446,000	$-27,517,000	$-23,524,000
EBIT	$2.47M	$8.85M	$-2,604,000	$-2,261,000	$283,000	$-11,615,000	$-24,657,000	$-26,532,000	$-34,207,000	$-62,047,000	$-28,105,000	$-24,110,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about AVDL

News

No news available

Company news will appear here when available

AVDL Competitors

Company	Ticker
Prestige Brand Holdings Inc	PBH
Select Medical Holdings	SEM
Biohaven Ltd.	BHVN
Dentsply Sirona Inc	XRAY
BioCryst Pharmaceuticals Inc	BCRX
Sarepta Therapeutics Inc	SRPT
Dynavax Technologies Corporation	DVAX
Fortrea Holdings Inc.	FTRE

Sector: Healthcare

AVDL Earnings: Beat Rate and Next Report

Beat rate: 4 of 8 quarters (50.0%)
Average surprise: 34.6%

AVDL Earnings Call

The latest AVDL earnings call transcript on file is labeled 2025Q2.

Read the 2025Q2 transcript

AVDL ETF Holders

GNG tracks 3 ETFs that hold AVDL. The largest weights:

Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.06% of the fund
iShares Russell 2000 ETF (IWM), 0.05% of the fund
Schwab U.S. Broad Market ETF (SCHB), <0.01% of the fund

Open the ETF Stock Exposure tool for AVDL

See insider activity

Frequently Asked Questions About AVDL

Does AVDL pay dividends?